Thelansis

Becker muscular dystrophy is in the category of inherited muscle wasting diseases caused by a gene abnormality (mutation) that results in deficient or abnormal production of the dystrophin protein (dystrophinopathies). Etiology- Becker muscular dystrophy (BMD) is caused by specific mutations in the DMD gene. The DMD gene gives the body instructions to make a protein called dystrophin. This protein helps stabilize and protect muscle fibers and may play a role in chemical signaling within cells. Epidemiology- Becker muscular dystrophy occurs in approximately 1 in 30,000 male births. The competitive landscape of Becker muscular dystrophy (BMD) includes country-specific approved as well as pipeline therapies. Any asset/product-specific designation or review and Accelerated Approval are being tracked and supplemented with analyst commentary. KOLs insights of Becker muscular dystrophy (BMD) across 8 MM market from the center of Excellence/ Public/ Private hospitals...